EPS Creative Health Technology Group Ltd.
The pharmaceutical development business is led by our subsidiary, EPS Medical Consultancy (Japan) Co., Ltd., and we aim to create a specialized healthcare trading company that connects Japan and China. The business contents of the Pharmaceutical Development Business are as follows.
The China CRO will provide clinical trial-related services in China for China and Japanese pharmaceutical companies. Our strength is that our project managers, who speak Japanese and Chinese manage the entire study, connecting Japanese clients and Chinese operations.
The licensing and financing support business introduces promising drug candidates born from academia and startups in Japan to overseas companies and supports fund raising and overseas expansion. In collaboration with Japan-China Medical Communication Center, we will also contribute to medical exchange businesses between Japan and China (training, promotional activities, support for participation in overseas exhibitions, etc.).
The IRO business supports the development and regulatory affairs of pharmaceuticals and medical devices in China, as well as the entry into China and Japan.
